We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.00 | 0.11% | 950.00 | 951.00 | 954.00 | 996.00 | 941.00 | 996.00 | 585,309 | 16:29:55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.26 | 681.27M |
TIDMCVSG
RNS Number : 4592K
CVS Group plc
14 December 2018
14 December 2018
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services, announces that 19,475 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "New Shares") were issued on 12 December as a result of the exercise of options at 0.2 pence per share by a former employee under the CVS Group Long Term Incentive Plan [2016/2018].
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 19 December 2018.
Following issue of the New Shares, the Company's total issued share capital will consist of 70,538,506 Ordinary Shares each carrying one voting right. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 70,538,506. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Contacts: Tel: 01379 644 288 CVS Group plc Simon Innes, Chief Executive Richard Fairman, Finance Director N+1 Singer (Nominated Adviser & Broker) Tel: 020 7496 3000 Aubrey Powell / Jen Boorer / Ben Farrow Rachel Hayes
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCDGBDDGXBBGIX
(END) Dow Jones Newswires
December 14, 2018 02:01 ET (07:01 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions